paclitaxel has been researched along with Sensation Disorders in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, N; Oishi, R | 1 |
| Fujiwara, S; Kanemura, M; Ohmichi, M; Ono, YJ; Sasaki, H; Tanaka, T; Tanaka, Y; Terai, Y; Tsunetoh, S | 1 |
| Jones, HR; Srinivasan, J | 1 |
| Kip, K; Overcash, J; Tofthagen, C | 1 |
| Durand, JP; Goldwasser, F | 1 |
| Burton, A; Cata, JP; Cordella, JV; Dougherty, PM; Weng, HR | 1 |
| Bogliun, G; Buda, A; Cavaletti, G; Colombo, N; Cundari, S; Fei, F; Franchi, D; La Presa, MT; Lissoni, A; Marzorati, L; Piatti, M; Zanna, C; Zincone, A | 1 |
| Israel, V; Jeffers, S; McRae, A; Muggia, FM; Natale, R; Rogers, M; Vafai, D; Zaretsky, S | 1 |
| Bär, PR; Gispen, WH; Hol, EM; Mandys, V; Sodaar, P | 1 |
| Natale, RB | 1 |
| Klastersky, J; Sculier, JP | 1 |
| Edwards, RP; Hart, LA; Kelley, JL; Kunschner, AJ; Price, FV | 1 |
| Bodine, SC; Carson, SR; Cedarbaum, JM; Cliffer, KD; DiStefano, PS; Garcia, K; Lewis, DR; Lindsay, RM; Nguyen, T; Park, JS; Radley, HE; Siuciak, JA; Stambler, N; Tonra, JR; Zlotchenko, E | 1 |
| Hirai, Y; Iwasaki, H; Matsui, H; Sekiya, S; Tate, S | 1 |
1 review(s) available for paclitaxel and Sensation Disorders
| Article | Year |
|---|---|
[Peripheral neuropathy induced by anticancer drugs].
Topics: Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Cold Temperature; Drugs, Chinese Herbal; Humans; Hyperalgesia; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Pyrazines; Sensation Disorders; Vincristine; Vitamin B 12 | 2013 |
5 trial(s) available for paclitaxel and Sensation Disorders
| Article | Year |
|---|---|
Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Nerve Growth Factor; Neurotoxicity Syndromes; Paclitaxel; Predictive Value of Tests; Prognosis; Sensation Disorders; Treatment Outcome; Uterine Cervical Neoplasms | 2004 |
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Sensation Disorders; Thrombocytopenia | 1995 |
A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Carboplatin; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sensation Disorders; Thrombocytopenia | 1995 |
[Definitive results of a phase I study of a chemotherapy regimen using cisplatin and paclitaxel for non-small cell bronchial cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Heart; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Remission Induction; Sensation Disorders | 1995 |
A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report.
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Disease Progression; Drug Resistance, Neoplasm; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Radiography; Remission Induction; Risk Factors; Salvage Therapy; Sensation Disorders; Survival Rate; Thrombocytopenia | 1997 |
8 other study(ies) available for paclitaxel and Sensation Disorders
| Article | Year |
|---|---|
Genitofemoral neuropathy after pelvic lymphadenectomy in patients with uterine corpus cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carboplatin; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hysterectomy; Incidence; Laparoscopy; Lymph Node Excision; Middle Aged; Ovariectomy; Paclitaxel; Pelvis; Peripheral Nerve Injuries; Peripheral Nervous System Diseases; Recovery of Function; Salpingectomy; Sensation Disorders; Time Factors; Uterine Neoplasms | 2015 |
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Coronary Restenosis; Disease Susceptibility; Drug-Eluting Stents; Humans; Male; Neural Conduction; Paclitaxel; Paresthesia; Polyneuropathies; Recurrence; Sensation Disorders; Sjogren's Syndrome | 2009 |
Falls in persons with chemotherapy-induced peripheral neuropathy.
Topics: Accidental Falls; Antineoplastic Combined Chemotherapy Protocols; Causality; Comorbidity; Docetaxel; Female; Humans; Logistic Models; Male; Middle Aged; Muscle Weakness; Neoplasm Staging; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Population Surveillance; Postural Balance; Prospective Studies; Risk Factors; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Taxoids | 2012 |
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine.
Topics: Adenocarcinoma; Aged; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Phytogenic; Cyclohexanols; Female; Humans; Neurotoxicity Syndromes; Ovarian Neoplasms; Paclitaxel; Paresthesia; Sensation Disorders; Venlafaxine Hydrochloride | 2002 |
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Female; Humans; Male; Middle Aged; Neoplasms; Nerve Fibers, Myelinated; Nociceptors; Paclitaxel; Pain; Pain Threshold; Psychomotor Performance; Sensation Disorders; Sensory Thresholds; Skin; Time Factors | 2004 |
Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Adrenocorticotropic Hormone; Amino Acid Sequence; Animals; Cell Division; Cell Movement; Cells, Cultured; Chick Embryo; Cisplatin; Dose-Response Relationship, Drug; Ganglia, Spinal; Laminin; Molecular Sequence Data; Nerve Tissue Proteins; Neurites; Neurons, Afferent; Paclitaxel; Peptide Fragments; Rats; Rats, Wistar; Schwann Cells; Sciatic Nerve; Sensation Disorders | 1994 |
Physiological characterization of Taxol-induced large-fiber sensory neuropathy in the rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Behavior, Animal; Electrophysiology; Female; Nerve Fibers; Paclitaxel; Rats; Rats, Sprague-Dawley; Sensation Disorders | 1998 |
[Evaluation of adverse effects including neurotoxicity of combination chemotherapy with paclitaxel and carboplatin].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Female; Humans; Hypesthesia; Nausea; Neuralgia; Ovarian Neoplasms; Paclitaxel; Pain Measurement; Sensation Disorders; Surveys and Questionnaires | 2000 |